Investors & Media

Press Releases

Date Title and Summary Additional Formats
Toggle Summary ImmunoGen, Inc. Announces Webcast of Presentation at Jefferies 2011 Global Healthcare Conference
WALTHAM, Mass.--(ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that Executive Vice President and CFO, Gregory Perry, will present at the
View HTML
Toggle Summary ImmunoGen, Inc. Announces Clinical Presentations at the ASCO 2011 Annual Meeting
WALTHAM, Mass., May 26, 2011 (BUSINESS WIRE) -- ImmunoGen, Inc . (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that favorable clinical data on two
View HTML